SCHEMBL9142113

SCHEMBL9142113

Cc1ccc(COC(=O)Oc2ccc([N+](=O)[O-])cc2)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.55
BCL9 O00512 1/20 0.49
CTNNB1 P35222 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.45
MAPT P10636 2/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
MAOB P27338 1/20 0.42
MGLL Q99685 2/20 0.41
ACHE P22303 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 1/20 0.40
PTPN7 P35236 1/20 0.40
PTPN12 Q05209 1/20 0.40
PTPN22 Q9Y2R2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8815110 0.90 HTR2A (0.55) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL9140032 0.85 HTR2A (0.57) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL19978980 0.84 HTR2A (0.56) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL4112112 0.82 HTR2A (0.74) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL17084531 0.81 HTR2A (0.63) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL25378334 0.81 ALDH1A1 (0.51) SMN1; SMN2MAPTALDH1A1POLBKMT2A
SCHEMBL6396644 0.81 HTR2A (0.65) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
Water SCHEMBL10938430 0.81 HTR2A (0.73) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
Water SCHEMBL10938437 0.81 HTR2A (0.73) HTR2ABCL9CTNNB1SMN1; SMN2MAPT
SCHEMBL9141672 0.80 HTR2A (0.55) HTR2ABCL9CTNNB1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453434-A Ocular hypotensive agents, treatment of glaucoma ALLERGAN, INC. (US) 1995-09-26 US disclosed
EP-0646598-A1 New pseudopeptides with antiviral activity containing valine BAYER AG (DE) 1995-04-05 EP disclosed